RU2018144784A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018144784A3 RU2018144784A3 RU2018144784A RU2018144784A RU2018144784A3 RU 2018144784 A3 RU2018144784 A3 RU 2018144784A3 RU 2018144784 A RU2018144784 A RU 2018144784A RU 2018144784 A RU2018144784 A RU 2018144784A RU 2018144784 A3 RU2018144784 A3 RU 2018144784A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061386 | 2016-05-19 | ||
| KR10-2016-0061386 | 2016-05-19 | ||
| PCT/KR2017/005172 WO2017200317A1 (ko) | 2016-05-19 | 2017-05-18 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018144784A RU2018144784A (ru) | 2020-06-19 |
| RU2018144784A3 true RU2018144784A3 (cg-RX-API-DMAC7.html) | 2020-08-11 |
| RU2751504C2 RU2751504C2 (ru) | 2021-07-14 |
Family
ID=60325324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018144784A RU2751504C2 (ru) | 2016-05-19 | 2017-05-18 | Применение карбамата для предупреждения или лечения невралгии тройничного нерва |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11207295B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3459542B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6960415B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102421013B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109310669B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017267160B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3024284C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3459542T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2887338T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX389613B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3459542T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3459542T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2751504C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017200317A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3035674T3 (en) | 2016-12-14 | 2025-09-08 | Sk Biopharmaceuticals Co Ltd | Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease |
| CA3112166A1 (en) * | 2018-09-21 | 2020-03-26 | Sk Biopharmaceuticals Co., Ltd. | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
| CA3116195A1 (en) * | 2018-10-19 | 2020-04-23 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| EA002401B1 (ru) * | 1996-12-31 | 2002-04-25 | Джи Пи Ай Нил Холдингс, Инк. | N-связанные мочевины и карбаматы сложных гетероциклических тиоэфиров |
| MXPA03007721A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuesto de carbamato para su uso en el tratamiento del dolor. |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP4227121B2 (ja) * | 2005-06-08 | 2009-02-18 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| MY155662A (en) * | 2009-06-22 | 2015-11-13 | Sk Biopharmaceuticals Co Ltd | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US20130252924A1 (en) * | 2010-11-11 | 2013-09-26 | Akron Molecules Gmbh | Compounds and Methods for Treating Pain |
| MX368735B (es) * | 2014-05-09 | 2019-10-14 | Tecnimede Sociedade Tecnico Medicinal S | (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina. |
-
2017
- 2017-05-16 KR KR1020170060713A patent/KR102421013B1/ko active Active
- 2017-05-18 US US16/302,860 patent/US11207295B2/en active Active
- 2017-05-18 JP JP2018560617A patent/JP6960415B2/ja active Active
- 2017-05-18 DK DK17799674.1T patent/DK3459542T3/da active
- 2017-05-18 ES ES17799674T patent/ES2887338T3/es active Active
- 2017-05-18 MX MX2018014081A patent/MX389613B/es unknown
- 2017-05-18 RU RU2018144784A patent/RU2751504C2/ru active
- 2017-05-18 PT PT177996741T patent/PT3459542T/pt unknown
- 2017-05-18 CN CN201780030912.5A patent/CN109310669B/zh active Active
- 2017-05-18 EP EP17799674.1A patent/EP3459542B1/en active Active
- 2017-05-18 WO PCT/KR2017/005172 patent/WO2017200317A1/ko not_active Ceased
- 2017-05-18 AU AU2017267160A patent/AU2017267160B2/en active Active
- 2017-05-18 CA CA3024284A patent/CA3024284C/en active Active
- 2017-05-18 PL PL17799674T patent/PL3459542T3/pl unknown
-
2021
- 2021-12-02 US US17/457,308 patent/US20220087976A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3459542A4 (en) | 2020-01-08 |
| DK3459542T3 (da) | 2021-09-13 |
| CA3024284C (en) | 2024-01-23 |
| JP2019516722A (ja) | 2019-06-20 |
| AU2017267160A1 (en) | 2018-12-13 |
| CN109310669A (zh) | 2019-02-05 |
| EP3459542B1 (en) | 2021-06-30 |
| CN109310669B (zh) | 2022-02-22 |
| JP6960415B2 (ja) | 2021-11-05 |
| US20220087976A1 (en) | 2022-03-24 |
| PT3459542T (pt) | 2021-08-24 |
| ES2887338T3 (es) | 2021-12-22 |
| EP3459542A1 (en) | 2019-03-27 |
| CA3024284A1 (en) | 2017-11-23 |
| AU2017267160B2 (en) | 2022-11-10 |
| KR102421013B1 (ko) | 2022-07-14 |
| PL3459542T3 (pl) | 2021-12-27 |
| BR112018073556A2 (pt) | 2019-03-19 |
| MX2018014081A (es) | 2019-09-02 |
| MX389613B (es) | 2025-03-20 |
| RU2751504C2 (ru) | 2021-07-14 |
| RU2018144784A (ru) | 2020-06-19 |
| US11207295B2 (en) | 2021-12-28 |
| WO2017200317A1 (ko) | 2017-11-23 |
| US20190175555A1 (en) | 2019-06-13 |
| KR20170131241A (ko) | 2017-11-29 |